Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy-Reference-Cited by-同舟云学术

Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy

Published:2021-08-31 Issue:36 Volume:13 Page:42411-42428
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Jiang Liangdi¹²,Gu Yongwei¹,Du Yue¹²,Tang Xiaomeng¹,Wu Xin³,Liu Jiyong¹^ORCID

Affiliation:

1. Department of Pharmacy, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

2. College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China

3. Shanghai Wei Er Biopharmaceutical Technology Co., Ltd., Shanghai 201799, China

Funder

Shanghai Municipal Health and Family Planning Commission

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.1c10325

Reference72 articles.

1. Treatment of Advanced Melanoma in 2020 and Beyond

2. Cancer Statistics, 2021

3. Nanocarrier-Based Drug Delivery for Melanoma Therapeutics

4. Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017

5. Multidrug resistance in cancer: role of ATP–dependent transporters

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin;Journal of Drug Delivery Science and Technology;2024-09

2. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review;Heliyon;2024-08

3. Recent progress in engineered extracellular vesicles and their biomedical applications;Life Sciences;2024-08

4. Exploring the Therapeutic Potential of Vesicular Nanocarrier Systems for Elimination of Skin Cancer;Current Medicinal Chemistry;2024-04-08

5. Engineered hsa‐miR‐455‐3p‐Abundant Extracellular Vesicles Derived from 3D‐Cultured Adipose Mesenchymal Stem Cells for Tissue‐Engineering Hyaline Cartilage Regeneration;Advanced Healthcare Materials;2024-04-03